Balloon vs. Self Expanding Transcatheter Valve for Degenerated Bioprosthesis

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 600 participants.

Also called NCT04843072

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 600 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04843072
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Austria, Canada, Denmark, France, Germany, Greece, Italy, Netherlands, Portugal, Switzerland, United Kingdom (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT04843072. Randomized; no masking; primary purpose treatment. Start 2021-05-01 (actual); primary completion 2028-06-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Balloon vs. Self Expanding Transcatheter Valve for Degenerated Bioprosthesis
Acronym
BASELINE
Condition
Valve Heart Disease
Intervention (Device)
EVOLUT R/PRO/PRO+/FX bioprosthesis
Intervention (Device)
Edwards Sapien S3/Ultra bioprosthesis
Intervention (Device)
MYVAL/Octacor/Octapro bioprosthesis
Lead sponsor
Erasmus Medical Center (class: other)
Collaborator
Cedars-Sinai Medical Center (class: other)

Record details

Record id
cardio:ct-nct04843072
Content hash
9eaa2a18972c675400005ef77ab07194dbd9b9308bb0ac31b5618903c3cae88a